Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 677 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Sunovion seeks FDA approval for LATUDA

These sNDAs are based on two six-week, double-blind, placebo-controlled Phase 3 clinical trials, PRogram to EValuate the Antidepressant Impact of Lurasidone (PREVAIL) 1 and PREVAIL 2. Sunovion Pharmaceuticals

Soligenix wins FDA clearance for SGX203 IND

With the IND clearance, Soligenix is expected to commence a Phase 1/2 pharmacokinetic (PK)/pharmacodynamic (PD) study of SGX203 in healthy adolescents and young adults. Soligenix senior vice president

Life Line selects Polymer CardioChek test system

The test system supports on-site lipid panel screening, which includes total cholesterol, HDL cholesterol, triglycerides, and LDL (calculated) along with glucose and provides the results in less than

Omeros files OMS824 IND with FDA

OMS824 targets and inhibits an enzyme expressed in areas of the brain associated with diseases that affect cognition, including schizophrenia and Huntington’s disease, PDE10. Omeros chairman and chief

Canada clears CardioComm HeartCheck ECG pen

The company has translated the language to meet Health Canada requirements for consumer product sales through the assistance of Lionbridge Technologies and modified the original Health Canada application